Tumor-suppressing viruses, genes, and drugs: innovative cancer therapy approaches
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego
Academic Press
©2002
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references and index Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer |
| Beschreibung: | 1 Online-Ressource (xv, 425 pages) |
| ISBN: | 0080549020 0124762492 9780080549026 9780124762497 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043115652 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 0080549020 |c electronic bk. |9 0-08-054902-0 | ||
| 020 | |a 0124762492 |c alk. paper |9 0-12-476249-2 | ||
| 020 | |a 9780080549026 |c electronic bk. |9 978-0-08-054902-6 | ||
| 020 | |a 9780124762497 |c alk. paper |9 978-0-12-476249-7 | ||
| 035 | |a (OCoLC)658232317 | ||
| 035 | |a (DE-599)BVBBV043115652 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99/406 |2 21 | |
| 245 | 1 | 0 | |a Tumor-suppressing viruses, genes, and drugs |b innovative cancer therapy approaches |c edited by Hiroshi Maruta |
| 264 | 1 | |a San Diego |b Academic Press |c ©2002 | |
| 300 | |a 1 Online-Ressource (xv, 425 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer | ||
| 650 | 4 | |a Antioncogènes | |
| 650 | 4 | |a Cancer / Thérapie génique | |
| 650 | 4 | |a Virus / Emploi en thérapeutique | |
| 650 | 4 | |a Cancer / Traitement / Innovations | |
| 650 | 4 | |a Cancer / Aspect moléculaire | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 2 | |a Tumeurs / thérapie | |
| 650 | 7 | |a Antioncogenes |2 fast | |
| 650 | 7 | |a Cancer / Gene therapy |2 fast | |
| 650 | 7 | |a Cancer / Molecular aspects |2 fast | |
| 650 | 7 | |a Cancer / Treatment / Technological innovations |2 fast | |
| 650 | 7 | |a Viruses / Therapeutic use |2 fast | |
| 650 | 7 | |a Cancer / Chimiothérapie |2 ram | |
| 650 | 7 | |a Cancer / Thérapie génique |2 ram | |
| 650 | 7 | |a Virus / Emploi en thérapeutique |2 ram | |
| 650 | 7 | |a Gentherapie |2 swd | |
| 650 | 7 | |a Tumorhemmung |2 swd | |
| 650 | 7 | |a Krebs <Medizin> |2 swd | |
| 650 | 7 | |a Pharmakotherapie |2 swd | |
| 650 | 4 | |a Neoplasms / therapy | |
| 650 | 4 | |a Antineoplastic Agents / therapeutic use | |
| 650 | 4 | |a Gene Therapy | |
| 650 | 4 | |a Genes, Tumor Suppressor | |
| 650 | 4 | |a Neoplasms / genetics | |
| 650 | 4 | |a Neoplasms / virology | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Antioncogenes | |
| 650 | 4 | |a Cancer |x Gene therapy | |
| 650 | 4 | |a Viruses |x Therapeutic use | |
| 650 | 4 | |a Cancer |x Treatment |x Technological innovations | |
| 650 | 4 | |a Cancer |x Molecular aspects | |
| 700 | 1 | |a Maruta, Hiroshi |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028539843 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175540050984960 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043115652 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)658232317 (DE-599)BVBBV043115652 |
| dewey-full | 616.99/406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/406 |
| dewey-search | 616.99/406 |
| dewey-sort | 3616.99 3406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04387nmm a2200769zc 4500</leader><controlfield tag="001">BV043115652</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080549020</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-08-054902-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0124762492</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-12-476249-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080549026</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-08-054902-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780124762497</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-0-12-476249-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)658232317</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043115652</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/406</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tumor-suppressing viruses, genes, and drugs</subfield><subfield code="b">innovative cancer therapy approaches</subfield><subfield code="c">edited by Hiroshi Maruta</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego</subfield><subfield code="b">Academic Press</subfield><subfield code="c">©2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xv, 425 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antioncogènes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Thérapie génique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus / Emploi en thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Traitement / Innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Aspect moléculaire</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs / thérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antioncogenes</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Gene therapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Molecular aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment / Technological innovations</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Viruses / Therapeutic use</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Chimiothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Thérapie génique</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Virus / Emploi en thérapeutique</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gentherapie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumorhemmung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Krebs <Medizin></subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genes, Tumor Suppressor</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antioncogenes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Gene therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viruses</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="x">Technological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Molecular aspects</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maruta, Hiroshi</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028539843</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043115652 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:17:54Z |
| institution | BVB |
| isbn | 0080549020 0124762492 9780080549026 9780124762497 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028539843 |
| oclc_num | 658232317 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xv, 425 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches edited by Hiroshi Maruta San Diego Academic Press ©2002 1 Online-Ressource (xv, 425 pages) txt rdacontent c rdamedia cr rdacarrier Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002 Includes bibliographical references and index Ch. 1. Oncolytic viruses: virotherapy for cancer -- Ch. 2. Reovirus therapy of Ras-associated cancers -- Ch. 3. Oncolytic herpes simplex virus (G207) therapy: from basic to clinical -- Ch. 4. p53 and its targets -- Ch. 5. Prospects for tumor suppressor gene therapy: RB as an example -- Ch. 6. CDK inhibitors: genes and drugs -- Ch. 7. CDK inhibitors: small molecular weight compounds -- Ch. 8. NF1 and other RAS-binding peptides -- Ch. 9. Cytoskeletal tumor suppressor genes -- Ch. 10. TGF-[beta] signaling and carcinogenesis -- Ch. 11. DAN gene -- Ch. 12. Design of hammerhead ribozymes and allosterically controllable maxizymes for cancer gene therapy -- Ch. 13. Inhibitors of angiogenesis -- Ch. 14. Geranylgeranylated RhoB mediates the apoptotic and antineoplastic effects of farnesyltransferase inhibitors: new insights into cancer cell suicide -- Ch. 15. RAS binding compounds -- Ch. 16. Actin-binding drugs: MKT-007 and chaetoglobosin K (CK) -- Ch. 17. Tyr kinase inhibitors as potential anticancer agents: EGF receptor and ABL kinases -- Ch. 18. Antagonists of Rho family GTPases: blocking PAKs, ACKs, and rock -- Ch. 19. Integrin antagonists as cancer therapeutics -- Ch. 20. Functional rescue of mutant p53 as a strategy to combat cancer Antioncogènes Cancer / Thérapie génique Virus / Emploi en thérapeutique Cancer / Traitement / Innovations Cancer / Aspect moléculaire MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs / thérapie Antioncogenes fast Cancer / Gene therapy fast Cancer / Molecular aspects fast Cancer / Treatment / Technological innovations fast Viruses / Therapeutic use fast Cancer / Chimiothérapie ram Cancer / Thérapie génique ram Virus / Emploi en thérapeutique ram Gentherapie swd Tumorhemmung swd Krebs <Medizin> swd Pharmakotherapie swd Neoplasms / therapy Antineoplastic Agents / therapeutic use Gene Therapy Genes, Tumor Suppressor Neoplasms / genetics Neoplasms / virology Medizin Antioncogenes Cancer Gene therapy Viruses Therapeutic use Cancer Treatment Technological innovations Cancer Molecular aspects Maruta, Hiroshi Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344 Aggregator Volltext |
| spellingShingle | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches Antioncogènes Cancer / Thérapie génique Virus / Emploi en thérapeutique Cancer / Traitement / Innovations Cancer / Aspect moléculaire MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs / thérapie Antioncogenes fast Cancer / Gene therapy fast Cancer / Molecular aspects fast Cancer / Treatment / Technological innovations fast Viruses / Therapeutic use fast Cancer / Chimiothérapie ram Cancer / Thérapie génique ram Virus / Emploi en thérapeutique ram Gentherapie swd Tumorhemmung swd Krebs <Medizin> swd Pharmakotherapie swd Neoplasms / therapy Antineoplastic Agents / therapeutic use Gene Therapy Genes, Tumor Suppressor Neoplasms / genetics Neoplasms / virology Medizin Antioncogenes Cancer Gene therapy Viruses Therapeutic use Cancer Treatment Technological innovations Cancer Molecular aspects |
| title | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches |
| title_auth | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches |
| title_exact_search | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches |
| title_full | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches edited by Hiroshi Maruta |
| title_fullStr | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches edited by Hiroshi Maruta |
| title_full_unstemmed | Tumor-suppressing viruses, genes, and drugs innovative cancer therapy approaches edited by Hiroshi Maruta |
| title_short | Tumor-suppressing viruses, genes, and drugs |
| title_sort | tumor suppressing viruses genes and drugs innovative cancer therapy approaches |
| title_sub | innovative cancer therapy approaches |
| topic | Antioncogènes Cancer / Thérapie génique Virus / Emploi en thérapeutique Cancer / Traitement / Innovations Cancer / Aspect moléculaire MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Tumeurs / thérapie Antioncogenes fast Cancer / Gene therapy fast Cancer / Molecular aspects fast Cancer / Treatment / Technological innovations fast Viruses / Therapeutic use fast Cancer / Chimiothérapie ram Cancer / Thérapie génique ram Virus / Emploi en thérapeutique ram Gentherapie swd Tumorhemmung swd Krebs <Medizin> swd Pharmakotherapie swd Neoplasms / therapy Antineoplastic Agents / therapeutic use Gene Therapy Genes, Tumor Suppressor Neoplasms / genetics Neoplasms / virology Medizin Antioncogenes Cancer Gene therapy Viruses Therapeutic use Cancer Treatment Technological innovations Cancer Molecular aspects |
| topic_facet | Antioncogènes Cancer / Thérapie génique Virus / Emploi en thérapeutique Cancer / Traitement / Innovations Cancer / Aspect moléculaire MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Tumeurs / thérapie Antioncogenes Cancer / Gene therapy Cancer / Molecular aspects Cancer / Treatment / Technological innovations Viruses / Therapeutic use Cancer / Chimiothérapie Gentherapie Tumorhemmung Krebs <Medizin> Pharmakotherapie Neoplasms / therapy Antineoplastic Agents / therapeutic use Gene Therapy Genes, Tumor Suppressor Neoplasms / genetics Neoplasms / virology Medizin Cancer Gene therapy Viruses Therapeutic use Cancer Treatment Technological innovations Cancer Molecular aspects |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=203344 |
| work_keys_str_mv | AT marutahiroshi tumorsuppressingvirusesgenesanddrugsinnovativecancertherapyapproaches |